M Witvrouw - JoVE Visualize

Showing results (81-90 of 91) with videos related to

Pageof 10

Sort By:

Journal of Medicinal Chemistry|April 12, 1996

Polyanion inhibitors of human immunodeficiency virus and other viruses. Part 2. Polymerized anionic surfactants derived from amino acids and dipeptidesA Leydet, H El Hachemi, B Boyer, et al.

Antimicrobial Agents and Chemotherapy|February 1, 1997

SRR-SB3, a disulfide-containing macrolide that inhibits a late stage of the replicative cycle of human immunodeficiency virusM Witvrouw, J Balzarini, C Pannecouque, et al.

AIDS (London, England)|November 14, 1998

Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countriesJ C Schmit, K Van Laethem, L Ruiz, et al.

Chemical & Pharmaceutical Bulletin|January 5, 2002

3-Benzamido, ureido and thioureidoimidazo[1,2-a]pyridine derivatives as potential antiviral agentsA Chaouni-Enabdallah, C Galtier, H Allouchi, et al.

Journal of Medicinal Chemistry|April 23, 1999

Chicoric acid analogues as HIV-1 integrase inhibitorsZ Lin, N Neamati, H Zhao, et al.

Journal of Medicinal Chemistry|July 5, 1996

Synthesis of acyclo-C-nucleosides in the imidazo[1,2-a]pyridine and pyrimidine series as antiviral agentsA Gueiffier, M Lhassani, A Elhakmaoui, et al.

Antimicrobial Agents and Chemotherapy|March 28, 1998

1,1,3-Trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine (TTD) derivatives: a new class of nonnucleoside human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors with anti-HIV-1 activityM Witvrouw, M E Arranz, C Pannecouque, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2000

Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populationsK Van Laethem, K Van Vaerenbergh, J C Schmit, et al.

Journal of Peptide Science : an Official Publication of the European Peptide Society|January 11, 2000

Charge modification of plasma and milk proteins results in antiviral active compoundsP J Swart, M C Harmsen, M E Kuipers, et al.

AIDS Research and Human Retroviruses|June 30, 2000

Presence of 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1",2"-oxath iole-2",2"-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patientsK Van Laethem, J C Schmit, H Pelemans, et al.

Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:

Pageof 10

Journal of Medicinal Chemistry|April 12, 1996

Polyanion inhibitors of human immunodeficiency virus and other viruses. Part 2. Polymerized anionic surfactants derived from amino acids and dipeptidesA Leydet, H El Hachemi, B Boyer, et al.

Antimicrobial Agents and Chemotherapy|February 1, 1997

SRR-SB3, a disulfide-containing macrolide that inhibits a late stage of the replicative cycle of human immunodeficiency virusM Witvrouw, J Balzarini, C Pannecouque, et al.

AIDS (London, England)|November 14, 1998

Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countriesJ C Schmit, K Van Laethem, L Ruiz, et al.

Chemical & Pharmaceutical Bulletin|January 5, 2002

3-Benzamido, ureido and thioureidoimidazo[1,2-a]pyridine derivatives as potential antiviral agentsA Chaouni-Enabdallah, C Galtier, H Allouchi, et al.

Journal of Medicinal Chemistry|April 23, 1999

Chicoric acid analogues as HIV-1 integrase inhibitorsZ Lin, N Neamati, H Zhao, et al.

Journal of Medicinal Chemistry|July 5, 1996

Synthesis of acyclo-C-nucleosides in the imidazo[1,2-a]pyridine and pyrimidine series as antiviral agentsA Gueiffier, M Lhassani, A Elhakmaoui, et al.

Antimicrobial Agents and Chemotherapy|March 28, 1998

1,1,3-Trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine (TTD) derivatives: a new class of nonnucleoside human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors with anti-HIV-1 activityM Witvrouw, M E Arranz, C Pannecouque, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2000

Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populationsK Van Laethem, K Van Vaerenbergh, J C Schmit, et al.

Journal of Peptide Science : an Official Publication of the European Peptide Society|January 11, 2000

Charge modification of plasma and milk proteins results in antiviral active compoundsP J Swart, M C Harmsen, M E Kuipers, et al.

AIDS Research and Human Retroviruses|June 30, 2000

Presence of 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1",2"-oxath iole-2",2"-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patientsK Van Laethem, J C Schmit, H Pelemans, et al.

Pageof 10